Geographical-level contributions of risk factors for HIV infections using generalized additive models: results from a cohort of South African women

References

• Abdool Karim, S. S., Richardson, B. A., Ramjee, G., Hoffman, I. F., Chirenje, Z. M., Taha, T., … Soto-Torres, L. (2011). Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS, 25(7), 957–966. doi: 10.1097/QAD.0b013e32834541d9
   PubMed Web of Science ®Google Scholar
• Balkus, J. E., Brown, E., Palanee, T., Nair, G., Gafoor, Z., Zhang, J., … Baeten, J. M. (2016). An empiric HIV risk scoring tool to predict HIV-1 acquisition in African women. JAIDS Journal of Acquired Immune Deficiency Syndromes, 72, 333–343. doi: 10.1097/QAI.0000000000000974
   PubMed Web of Science ®Google Scholar
• De Jesus, M., Taylor, J., Maine, C., & Nalls, P. (2016). A one-size-fits-all HIV prevention and education approach?: Analyzing and interpreting divergent HIV risk perceptions between African American and East African immigrant women in Washington, DC. Sexually Transmitted Diseases, 43(2), 78–83. doi: 10.1097/OLQ.0000000000000386
   PubMed Web of Science ®Google Scholar
• De Visser, R. (2005). One size fits all? Promoting condom use for sexually transmitted infection prevention among heterosexual young adults. Health Education Research, 20(5), 557–566. doi: 10.1093/her/cyh015
   PubMed Web of Science ®Google Scholar
• The Global Fund. (2013). The global fund’s new funding model: Fourth replenishment (2014–2016). Geneva: The Global Fund.
   Google Scholar
• Gray, R. H., & Wawer, M. J. (2008). Reassessing the hypothesis on STI control for HIV prevention. The Lancet, 371, 2064–2065. doi: 10.1016/S0140-6736(08)60896-X
   PubMed Web of Science ®Google Scholar
• Hayes, R., Jones, D. W., Celum, C., Wijgert, J., & Wasserheit, R. J. (2010). Treatment of sexually transmitted infections for HIV prevention: End of the road or new beginning? AIDS, 24(4). doi: 10.1097/01.aids.0000390704.35642.47
   Google Scholar
• Hosmer, D. W., & Lemeshow, S. (1999). Applied survival analysis: Regression modelling of time to event data. New York: John Wiley.
   Google Scholar
• Jewkes, R., Flood, M., & Lang, J. (2015). From work with men and boys to changes of social norms and reduction of inequities in gender relations: A conceptual shift in prevention of violence against women and girls. The Lancet, 385, 1580–1589. doi: 10.1016/S0140-6736(14)61683-4
   PubMed Web of Science ®Google Scholar
• Joint United Nations Programme on HIV/AIDS (UNAIDS). (2013). Location: Connecting people faster to HIV services. Geneva: UNAIDS.
   Google Scholar
• Laga, M., Manoka, A., Kivuvu, M., Malele, B., Tuliza, M., Nzila, N., … Piot, P. (1993). Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study. AIDS, 7, 95–102. doi: 10.1097/00002030-199301000-00015
   PubMed Web of Science ®Google Scholar
• Leon, N., Naidoo, P., Mathews, C., Lewin, S., & Lombard, C. (2010). The impact of provider initiated (opt-out) HIV testing and counseling of patients with sexually transmitted infection in Cape Town, South Africa: A controlled trial. Implementation Science, 5, 8. doi: 10.1186/1748-5908-5-8
   PubMed Web of Science ®Google Scholar
• Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., … Chirenje, Z. M. (2015). Tenofovir based preexposure prophylaxis for HIV infection among African women. New England Journal of Medicine, 372, 509–518. doi: 10.1056/NEJMoa1402269
   PubMed Web of Science ®Google Scholar
• Martin, H. L., Richardson, B. A., Nyange, P., Lavreys, L., Hillier, S., Chohan, B., … Kreiss, J. (1999). Vaginal Lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. The Journal of Infectious Diseases, 180, 1863–1868. doi: 10.1086/315127
   PubMed Web of Science ®Google Scholar
• McClelland, R. S., Richardson, B. A., Hassan, W. M., Chohan, V., Lavreys, L., Mandaliya, K., … Holmes, K. K. (2008). Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: Results of a randomized trial. The Journal of Infectious Diseases, 197, 1361–1368. doi: 10.1086/587490
   PubMed Web of Science ®Google Scholar
• McCormack, S., Ramjee, G., Kamali, A., Rees, H., Crook, A. M., Gafos, M., … Weber, J. (2010). PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): A phase 3, randomised, double-blind, parallel-group trial. The Lancet, 376, 1329–1337. doi: 10.1016/S0140-6736(10)61086-0
   PubMed Web of Science ®Google Scholar
• Microbicide Trials Network (MTN). (2011). MTN statement on decision to discontinue use of Tenofovir gel in VOICE, a major HIV prevention study in women. Retrieved from http://www.mtnstopshiv.org/node/3909
   Google Scholar
• National Department of Health. (2009). 2008 national antenatal sentinel HIV and syphilis prevalence survey, South Africa. Pretoria: Author.
   Google Scholar
• Ostermanna, J., Njau, B., Mtuy, T., Brown, D. S., Muhlbacher, A., & Thielman, N. (2014). One size does not fit all: HIV testing preferences differ among high-risk groups in northern Tanzania. AIDS Care, 27, 5.
   Web of Science ®Google Scholar
• Padian, N. S., van der Straten, A., Ramjee, G., Chipato, T., de Bruyn, G., Blanchard, K., … McIntyre, J. (2007). Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: A randomised controlled trial. The Lancet, 370, 251–261. doi: 10.1016/S0140-6736(07)60950-7
   PubMed Web of Science ®Google Scholar
• Ramjee, G., Moonsamy, S., Abbai, N. S., Wand, H., & He, W. (2016). Individual and population level impact of key HIV risk factors on HIV incidence rates in Durban, South Africa. PLoS One, 11, e0153969. doi: 10.1371/journal.pone.0153969
   PubMed Web of Science ®Google Scholar
• Skoler-Karpoff, S., Ramjee, G., Ahmed, K., Altini, L., Plagianos, M. G., Friedland, B., … Lahteenmaki, P. (2008). Efficacy of Carraguard for prevention of HIV infection in women in South Africa: A randomised, double-blind, placebo-controlled trial. The Lancet, 372, 1977–1987. doi: 10.1016/S0140-6736(08)61842-5
   PubMed Web of Science ®Google Scholar
• Tanser, F., Barnighausen, T., Cooke, G. S., & Newell, M. L. (2009). Localized spatial clustering of HIV infections in a widely disseminated rural South African epidemic. International Journal of Epidemiology, 38(4), 1008–1016. doi: 10.1093/ije/dyp148
   PubMed Web of Science ®Google Scholar
• Tanser, F., de Oliveira, T., Maheu-Giroux, M., & Bärnighausen, T. (2014). Concentrated HIV sub-epidemics in generalized epidemic settings. Current Opinion in HIV and AIDS, 9(2), 115–125. doi: 10.1097/COH.0000000000000034
   PubMed Web of Science ®Google Scholar
• Wand, H., & Ramjee, G. (2010). Targeting the hotspots: Investigating spatial and demographic variations in HIV infection in small communities in South Africa. Journal of the International AIDS Society, 13(1), 41. doi: 10.1186/1758-2652-13-41
   PubMedGoogle Scholar
• Wand, H., & Ramjee, G. (2011). Combined impact of sexual risk behaviors for HIV seroconversion among women in Durban, South Africa: Implications for prevention policy and planning. AIDS and Behavior, 15, 479–486. doi: 10.1007/s10461-010-9845-2
   PubMed Web of Science ®Google Scholar
• Wand, H., Reddy, T., Naidoo, S., Moonsamy, S., Siva, S., Morar, N. S., & Ramjee, G. (2017). A simple risk prediction algorithm for HIV transmission: Results from HIV prevention trials in KwaZulu-Natal, South Africa (2002–2012). AIDS Behavior, 22(1), 325–336. doi: 10.1007/s10461-017-1785-7
   Web of Science ®Google Scholar
• Wand, H., Whitaker, C., & Ramjee, G. (2011). Geoadditive models to assess spatial variation of HIV infections among women in local communities of Durban, South Africa. International Journal of Health Geographics, 10, 28. doi: 10.1186/1476-072X-10-28
   PubMed Web of Science ®Google Scholar
• Wood, S. N. (2004). Stable and efficient multiple smoothing parameter estimation for generalized additive models. Journal of the American Statistical Association, 99, 673–686. doi: 10.1198/016214504000000980
   Web of Science ®Google Scholar